A股異動丨雲天化(600096.SH)漲逾4% 2021年度淨利預增1186.59%-1260.11%
格隆匯1月11日丨雲天化(600096.SH)漲逾4%,報19.66元,總市值361億元。雲天化昨日公佈2021年度業績預增公吿,公司預計2021年度歸屬於上市公司股東的淨利潤35億元至37億元,上年同期淨利潤2.72億元,同比增加1186.59%至1260.11%。2021年度各項政府補助、資產處置等非經常性損益金額1.1億元左右,上年同期非經常性損益金額2.24億元,同比減少1.14億元左右。扣除上述非經常性損益後,公司歸屬於上市公司股東的淨利潤預計同比增加33.42億元至35.42億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.